Active Surveillance: Very Much "Preferred" for Low-Risk Prostate Cancer. Issue 2 (15th February 2022) - Cooperberg, Matthew R.; Lin, Daniel W.; Morgan, Todd M.; Chapin, Brian F.; Chen, Ronald C.; Eggener, Scott E.